Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/20/19 → 8/31/22 |
Funding
- Covance Inc. (Prot #16-214-02)
- Nektar Therapeutics (Prot #16-214-02)
Prot #16-214-02: A Phase 1/2, Open-label, Multicenter Study of the Combination of NKTR-214 and Nivolumab or the Combination of NKTR-214, Nivolumab, and Other Anti-Cancer Therapies in Patients with Select Locally Advanced or Metastatic Solid Tumor Malignan
- Chae, Young Kwang (PD/PI)
- Sosman, Jeffrey Alan (Other)
- Villaflor, Victoria Meucci (Other)
Project: Research project